CBIO
Crescent Biopharma, Inc.
14.30$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -64.5% | -90.4% | -100.0% | – | |
| – | -91.4% | -37.2% | -15.0% | -34.6% | +232.6% | – | – | +81,300.0% | -96.7% | – | – | – | |
| – | – | -246.2% | – | – | – | – | – | – | -62.5% | -90.4% | – | – | |
| – | -0.1% | +13.9% | +4.3% | -72.7% | +718.1% | -24.3% | +13.7% | +68.4% | +367.0% | -81.2% | +8.3% | – | |
| – | -4.6% | +18.0% | -20.0% | -1.6% | -21.2% | +13.9% | +148.8% | -38.1% | +32.0% | +7.6% | +11.2% | – | |
| – | -2.2% | +15.8% | -6.8% | +8.5% | +53.0% | -17.3% | +47.8% | +23.1% | +295.3% | -74.8% | +2.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +30.5% | -3.5% | -100.0% | – | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -177.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.